These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18831463)

  • 1. [Early Rheumatism Treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2008 Sep; 31(9):323. PubMed ID: 18831463
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate in juvenile idiopathic arthritis: answers and questions.
    Ravelli A; Martini A
    J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biologic agents in juvenile idiopathic arthritis].
    Gomes JA
    Acta Reumatol Port; 2007; 32(1):13-4. PubMed ID: 17450760
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of methotrexate in children.
    Passo MH; Hashkes PJ
    Bull Rheum Dis; 1998 Aug; 47(5):1-5. PubMed ID: 9735507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate.
    Londino AV; Blatt J; Knisely AS
    J Rheumatol; 1998 Jun; 25(6):1245-6. PubMed ID: 9632099
    [No Abstract]   [Full Text] [Related]  

  • 6. Juvenile rheumatoid arthritis.
    Simmons BP; Nutting JT; Bernstein RA
    Hand Clin; 1996 Aug; 12(3):573-89. PubMed ID: 8842721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate: new indication. Idiopathic juvenile arthritis: the standard immunosuppressant. Lengthy follow-up, but mediocre comparative assessment.
    Prescrire Int; 2008 Feb; 17(93):15. PubMed ID: 18354862
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Still's disease (Systemic-Onset Juvenile Idiopathic Arthritis)].
    Quartier P
    Arch Pediatr; 2008 Jun; 15(5):865-6. PubMed ID: 18582783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Juvenile rheumatoid arthritis. What is the optimal treatment?].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2007 Sep; 30(9):349-50. PubMed ID: 17912880
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrophoderma and juvenile idiopathic arthritis.
    Ramanan AV; Baildam EM; Judge MR
    Ann Rheum Dis; 2001 Sep; 60(9):900-1. PubMed ID: 11534508
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials in pediatric rheumatology: comment on the editorial by Lehman.
    DeWitt EM; Ardoin SP; Rabinovich CE; Schanberg LE
    Arthritis Rheum; 2008 Apr; 58(4):1202-3; author reply 1203. PubMed ID: 18383362
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis.
    Dyer JA; Guitart J; Klein-Gitelman M; Mancini AJ
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S65-8. PubMed ID: 17938028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
    Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
    Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).
    Ohlsson V; Baildam E; Foster H; Jandial S; Pain C; Strike H; Ramanan AV
    Rheumatology (Oxford); 2008 Apr; 47(4):555-6. PubMed ID: 18321945
    [No Abstract]   [Full Text] [Related]  

  • 16. Performing trials in children with rheumatic diseases: comment on the editorial by Lehman.
    Ruperto N; Martini A; Lovell DJ; Giannini EH; ;
    Arthritis Rheum; 2008 Apr; 58(4):1201-2; author reply 1203. PubMed ID: 18383366
    [No Abstract]   [Full Text] [Related]  

  • 17. When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
    Prince FH; Twilt M; Simon SC; van Rossum MA; Armbrust W; Hoppenreijs EP; Kamphuis S; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; ten Cate R; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 Jul; 68(7):1228-9. PubMed ID: 19525408
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate therapy for psoriatic arthritis: reappraisal of an old remedy.
    Saketkoo LA; Cuchacovich R; Espinoza LR
    J Rheumatol; 2008 Mar; 35(3):369-71. PubMed ID: 18322970
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S; Liebert UG; Borte M; Sack U
    Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
    Verma S; Gupta R; Lodha R; Kabra SK
    Indian Pediatr; 2009 Mar; 46(3):264-5. PubMed ID: 19346579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.